Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in in vitro and in vivo models of Parkinson’s disease

Parkinson’s Disease (PD) is a chronic progressive neurodegenerative disease. Current treatments for PD are symptomatic and only increase striatal dopamine levels. Proactive neuroprotective approaches that slow the progression of PD and maintain appropriate dopamine neuron populations are needed to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Judith, Taylor, Shane K.B., Gupta, Anika, Amin, Niranjana, Pant, Harish, Gupta, Bhagwati P., Mishra, Ram K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559888/
https://www.ncbi.nlm.nih.gov/pubmed/36246507
http://dx.doi.org/10.1016/j.crneur.2021.100006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559888/
https://www.ncbi.nlm.nih.gov/pubmed/36246507
http://dx.doi.org/10.1016/j.crneur.2021.100006

Ejemplares similares